Nε-(carboxymethyl)lysine during the early development of hypertension

Annals of the New York Academy of Sciences

Volumn 1126, Issue , 2008, Pages 201-204

  Baumann, Marcus ^a,b   Stehouwer, Coen ^c   Scheijen, Jean ^c   Heemann, Uwe ^b   Struijker Boudier, Harry ^a   Schalkwijk, Casper ^c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hypertension; N (carboxymethyl)lysine; Oxidative stress; Renal function; Spontaneously hypertensive rat

Indexed keywords

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; LYSINE DERIVATIVE; CREATININE; DRUG DERIVATIVE; LYSINE; N(6) CARBOXYMETHYLLYSINE; N(6)-CARBOXYMETHYLLYSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE COURSE; GLOMERULAR DYSFUNCTION; HYPERTENSION; KIDNEY FUNCTION; NEPHRITIS; NONHUMAN; OXIDATIVE STRESS; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT; ALBUMINURIA; ANIMAL; ARTICLE; HEART RATE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; WISTAR KYOTO RAT;

RATTUS;

ALBUMINURIA; ANIMALS; BLOOD PRESSURE; CREATININE; GLYCOSYLATION END PRODUCTS, ADVANCED; HEART RATE; HUMANS; HYPERTENSION; LYSINE; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; RATS, INBRED WKY;

EID: 42549163205     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1433.004     Document Type: Conference Paper

References (26)

1. 1 Singh, R. et al. 2001. Advanced glycation end‐products: a review. Diabetologia 44: 129–146.
2. 2 Morcos, M. et al. 2002. Activation of tubular epithelial cells in diabetic nephropathy. Diabetes 51: 3532–3544.
3. 3 Vasdev, S. et al. 1998. Role of aldehydes in fructose induced hypertension. Mol. Cell Biochem. 181: 1–9.
4. 4 Bianchi, G. et al. 1974. Blood pressure changes produced by kidney cross‐transplantation between spontaneously hypertensive rats and normotensive rats. Clin. Sci. Mol. Med. 47: 435–448.
5. 5 Guidi, E. et al. 1996. Hypertension may be transplanted with the kidney in humans: a long‐term historical prospective follow‐up of recipients grafted with kidneys coming from donors with or without hypertension in their families. J. Am. Soc. Nephrol. 7: 1131–1138.
6. 6 Baumann, M., E.H. Van, J.J.R. Hermans, et al. 2004. Functional and Structural Postglomeruar Aterations in the Kidney of Prehypertensive Spontaneously Hypertensive Rats. Clin. Exp. Hypertens 26: 663–672.
7. 7 Baumann, M. et al. 2007. Transient AT1 receptor‐inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age. J. Hypertens 25: 207–215.
8. 8 Sanders, M.W. et al. 2005. High sodium intake increases blood pressure and alters renal function in intrauterine growth‐retarded rats. Hypertension 46: 71–75.
9. 9 Lutz, J. et al. 2006. Angiotensin type 1 and type 2 receptor blockade in chronic allograft nephropathy. Kidney Int. 70: 1080–1088.
10. 10 Schalkwijk, C.G. et al. 2004. Increased accumulation of the glycoxidation product Nepsilon‐(carboxymethyl)lysine in hearts of diabetic patients: generation and characterisation of a monoclonal anti‐CML antibody. Biochim. Biophys. Acta 1636: 82–89.
11. 11 Schram, M.T. et al. 2005. Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. Hypertension 46: 232–237.
12. 12 Rodriguez‐Iturbe, B. et al. 2002. Reduction of renal immune cell infiltration results in blood pressure control in genetically hypertensive rats. Am. J. Physiol. Renal Physiol. 282: F191–F201.
13. 13 Jones, D.P. 2002. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol. 348: 93–112.
14. 14 Den Hartog, G.J. et al. 2003. Superoxide dismutase: the balance between prevention and induction of oxidative damage. Chem. Biol. Interact. 145: 33–39.
15. 15 Wang, X. et al. 2004. Increased methylglyoxal and advanced glycation end products in kidney from spontaneously hypertensive rats. Kidney Int. 66: 2315–2321.
16. 16 Wang, X. et al. 2007. Attenuation of hypertension development by aminoguanidine in spontaneously hypertensive rats: role of methylglyoxal. Am. J. Hypertens 20: 629–636.
17. 17 Wang, X. et al. 2005. Vascular methylglyoxal metabolism and the development of hypertension. J. Hypertens 23: 1565–1573.
18. 18 Wihler, C. et al. 2005. Renal accumulation and clearance of advanced glycation end‐products in type 2 diabetic nephropathy: effect of angiotensin‐converting enzyme and vasopeptidase inhibition. Diabetologia 48: 1645–1653.
19. 19 Stewart, T. et al. 2005. Kidney immune cell infiltration and oxidative stress contribute to prenatally programmed hypertension. Kidney Int. 68: 2180–2188.
20. 20 Wagner, Z. et al. 2001. N(epsilon)‐(carboxymethyl)lysine levels in patients with type 2 diabetes: role of renal function. Am. J. Kidney Dis. 38: 785–791.
21. 21 Ofstad, J. & B.M. Iversen. 2005. Glomerular and tubular damage in normotensive and hypertensive rats. Am. J. Physiol. Renal Physiol. 288: F665–F672.
22. 22 Nakazono, K. et al. 1991. Does superoxide underlie the pathogenesis of hypertension? Proc. Natl. Acad. Sci. USA 88: 10045–10048.
23. 23 Wilcox, C.S. 2005. Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am. J. Physiol. Regul. Integr. Comp. Physiol. 289: R913–R935.
24. 24 Touyz, R.M. & E.L. Schiffrin. 2001. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D‐dependent NAD(P)H oxidase‐sensitive pathways. J. Hypertens 19: 1245–1254.
25. 25 Struijker Boudier, H.A. et al. 2003. The heart, macrocirculation and microcirculation in hypertension: a unifying hypothesis. J. Hypertens Suppl. 21: S19–S23.
26. 26 Rodriguez‐Iturbe, B. et al. 2004. Oxidative stress, renal infiltration of immune cells, and salt‐sensitive hypertension: all for one and one for all. Am. J. Physiol. Renal Physiol. 286: F606–F616.